Human alpha1-proteinase inhibitor for treating emphysema ID856
In development [GID-HST10017] Expected publication date: TBC
Search results
31 results
-
-
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
In development [GID-HST10007] Expected publication date: TBC
-
Afamelanotide for treating erythropoietic protoporphyria [ID927]
In development [GID-HST10009] Expected publication date: TBC
-
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]
In development [GID-HST10033] Expected publication date: TBC
-
Sebelipase alfa for treating Wolman disease [ID3995]
In development [GID-HST10047] Expected publication date: TBC
-
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development [GID-HST10037] Expected publication date: TBC
-
Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests
In development [GID-DG10038] Expected publication date: TBC
-
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
In development [GID-HST10004] Expected publication date: TBC
-
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
In development [GID-HST10050] Expected publication date: TBC
-
Clopidogrel genotype testing after ischaemic stroke (provisional title)
In development [GID-DG10054] Expected publication date: 16 August 2023
-
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (review of HST3) ID1642
In development [GID-HST10044] Expected publication date: 25 January 2023
-
Lysosomal acid lipase deficiency - sebelipase alfa [ID737]
In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC
-
Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]
In development [GID-HST10038] Expected publication date: TBC
-
Automated ankle brachial pressure index measurement devices for assessing peripheral arterial disease in people with leg ulceration
In development [GID-DG10049] Expected publication date: 12 April 2023
-
Software with artificial intelligence derived algorithms for automated detection and analysis of lung nodules from CT scan images
In development [GID-DG10046] Expected publication date: 28 June 2023
-
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency [ID3791]
In development [GID-HST10052] Expected publication date: 29 March 2023
-
MRI fusion biopsy in people with suspected prostate cancer
In development [GID-DG10050] Expected publication date: 17 May 2023
-
Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818
In development [GID-HST10040] Expected publication date: TBC
-
Transperineal biopsy for diagnosing prostate cancer
In development [GID-DG10043] Expected publication date: TBC
-
Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral for people with a change in bowel habit or abdominal pain
In development [GID-DG10036] Expected publication date: 15 November 2023
-
Genedrive MT-RNR1 ID System for detecting single nucleotide polymorphism m.1555A G in newborn babies (provisional title)
In development [GID-DG10057] Expected publication date: 13 September 2023
-
Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223
In development [GID-HST10019] Expected publication date: TBC
-
Devices for remote continuous monitoring of people with Parkinson's disease
In development [GID-DG10047] Expected publication date: 25 January 2023
-
Onasemnogene abeparvovec for treating pre-symptomatic spinal muscular atrophy (MAA partial review of HST 15) [ID4051]
In development [GID-HST10053] Expected publication date: 25 May 2023
-
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease (CAD) (provisional title)
In development [GID-DG10062] Expected publication date: 16 February 2023
-
MRI-based technologies for assessing non-alcoholic fatty liver disease
In development [GID-DG10045] Expected publication date: 26 October 2022
-
Velmanase alfa for treating alpha-mannosidosis [ID800]
In development [GID-HST10010] Expected publication date: TBC
-
Velmanase alfa for treating alpha-mannosidosis [ID800]: evaluation consultation
We are listening to your views on this Highly specialised technology. Comments close 16 August 2022.
-
Artificial intelligence (AI) software to help clinical decision making in stroke
In development [GID-DG10044] Expected publication date: TBC
-
KardiaMobile 6L for measuring cardiac QT interval in people having antipsychotic medication
In development [GID-DG10048] Expected publication date: 07 October 2022
-
KardiaMobile 6L for measuring cardiac QT interval in people having antipsychotic medication: diagnostics consultation
We are listening to your views on this Diagnostics guidance. Comments close 25 August 2022.